Onkure Therapeutics, Inc.
OKUR
Revenue
0.00
0.000.00%
-Assets
78.72M
▼-5.92M▼-7.00%
3 Months ChangeLiabilities
1.85M
▼-1.55M▼-45.60%
3 Months ChangeFree Cash Flow
-9.22M
▼-177.00k▼-1.96%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-08
Form 8-K
ID: 0001193125-24-234487
2024-10-02
Form 8-K
ID: 0001193125-24-231281
2024-09-20
Form 8-K
ID: 0001193125-24-222429
2024-09-13
Form 8-K
ID: 0001193125-24-218879
2024-08-13
Form 10-Q
ID: 0000950170-24-096411
2024-08-13
Form 8-K
ID: 0000950170-24-096127
2024-05-13
Form 8-K
ID: 0001193125-24-136785
2024-05-07
Form 10-Q
ID: 0000950170-24-054452
2024-05-07
Form 8-K
ID: 0000950170-24-054442
2024-03-28
Form 8-K
ID: 0000950170-24-038003